Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01241318Phase 2Completed

Zambia Chlorhexidine Application Trial

Role: collaborator

NCT02386592Not ApplicableCompleted

Prevention of Nosocomial Bacteremia Among Zambian Neonates

Role: collaborator

NCT02234726Not ApplicableCompleted

Improving Early Childhood Development in Zambia

Role: lead

NCT02866097Not ApplicableUnknown

Integrated Community Case Management Study in Eastern Province, Zambia

Role: lead

NCT02479659Not ApplicableCompleted

Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services

Role: collaborator

All 5 trials loaded